Mojgan Rastegar BSc, MSc, BEA, PhD

Dr. Mojgan Rastegar received her PhD and DEA (Diplôme d’Etudes Approfondies) from the Université Catholique de Louvain (UCL) Brussels, Belgium; and her MSc and BSc from Tehran University of Medical Sciences, and Tehran University, Tehran, Iran. Her first post-doctoral training was in the area of Epigenetic Control of Multi-Drug Resistance in Breast Cancer and Leukemia which was done in Indiana University Cancer Center, IUPUI, IN, USA. In Canada, Dr. Rastegar further studied the Regulatory role of Epigenetics and Chromatin Remodelling in Stem Cell Differentiation, Mammalian Development, and Brain Disorders in McGill University in Montreal, Quebec with Professor Mark Featherstone; and Hospital for Sick Children, Toronto, Ontario with Professor James Ellis. Dr. Rastegar is currently an Associate Professor in the Department of Biochemistry and Medical Genetics, and a member of the Regenerative Medicine Program at the University of Manitoba. She serves as an editor of Frontiers in Genetics (Epigenetics) and reviewer of Acta Neuropathologica, Scientific Reports, Journal of Biological Chemistry, PLOS ONE, Autism research, Molecular Pathology, Molecular cancer, and Current Genomics among others. She serves as a provincial, national and international grant reviews and has served on provincial and national review panels. Her lab applies molecular and stem cell biology techniques along with gene therapy strategies to investigate the underlying pathobiology of human disease.